Robert Reindollar
Gastroenterology · Salisbury, NCNPI 1851382287
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $381,305 of the $430,003 with a category attached, or 88.7%. 19 manufacturers reported payments, led by AbbVie at 39.3% of the total. Among gastroenterology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 466 payments — averaging $922.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$169K
- Intercept Pharmaceuticals, Inc.$166K
- Gilead$93K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$440
- Madrigal Pharmaceuticals$336
- Takeda Pharmaceuticals U.S.A., Inc.$198
- plus $739 from 13 others
Across 225 payments — averaging $9154.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Intercept Pharmaceuticals, Inc.$1.6M
- Bristol Myers Squibb$197K
- Gilead$163K
- AbbVie$52K
- Intercept Pharma Europe Ltd.$26K
- Merck$500
What the payments were for
- Consulting fees$15,0003%
- Speaking & faculty fees$381,30589%
- Travel & lodging$21,9825%
- Food & beverage$11,7163%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 176 | $169,183 |
| Intercept Pharmaceuticals, Inc. | 109 | $165,731 |
| Gilead | 98 | $93,376 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 22 | $440 |
| Madrigal Pharmaceuticals | 9 | $336 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $198 |
| Johnson & Johnson | 9 | $190 |
| Bristol Myers Squibb | 13 | $173 |
| Daiichi Sankyo Inc. | 5 | $87 |
| Novo Nordisk | 2 | $52 |
| Ironwood Pharmaceuticals, Inc | 2 | $49 |
| Ardelyx, Inc. | 3 | $46 |
| Pfizer | 2 | $37 |
| Nestle Healthcare Nutrition Inc. | 2 | $29 |
| Orexo US, Inc. | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Organon | 1 | $14 |
| Evoke Pharma, Inc. | 1 | $14 |
| Sanofi | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$430,003 in reported general payments places this provider in the 95th percentile of 610 gastroenterology providers in North Carolina.
Other gastroenterology in Salisbury
- Vineet KorrapatiSalisbury$42K
- Kiran JagarlamudiSalisbury$35K
- Stephen DealCharlotte$945K
- Fred FowlerCharlotte$932K
- Paul WatkinsChapel Hill$876K
- Nilesh LodhiaCharlotte$735K
- Evan DellonChapel Hill$431K
- Andrew StormWinston Salem$426K
- John PoulosFayetteville$407K
- Manal AbdelmalekDurham$402K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.